Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $388.96 | 1 | 52.9% |
| Food and Beverage | $346.56 | 10 | 47.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $388.96 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $122.00 | 1 | $0 (2019) |
| Celgene Corporation | $115.91 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $108.65 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $266.77 | 4 | Novartis Pharmaceuticals Corporation ($122.00) |
| 2018 | $451.94 | 6 | Actelion Pharmaceuticals US, Inc. ($388.96) |
| 2017 | $16.81 | 1 | Janssen Biotech, Inc. ($16.81) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | Cash or cash equivalent | $115.91 | General |
| Category: Dermatology | ||||||
| 04/11/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: DERMATOLOGY | ||||||
| 04/08/2019 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Immunology | ||||||
| 01/14/2019 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Immunology | ||||||
| 10/25/2018 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Immunology | ||||||
| 08/21/2018 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $388.96 | General |
| 08/09/2018 | Janssen Biotech, Inc. | Tremfya (Drug), Tremfya | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Immunology | ||||||
| 06/05/2018 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Immunology | ||||||
| 05/01/2018 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Immunology | ||||||
| 02/01/2018 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Immunology | ||||||
| 07/26/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 9 | 594 | 665 | $94,054 | $20,745 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 206 | 213 | $30,246 | $7,071 | 23.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 154 | 206 | $16,480 | $5,034 | 30.5% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 89 | 89 | $12,371 | $2,625 | 21.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 36 | 38 | $12,164 | $2,009 | 16.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 33 | 33 | $11,319 | $1,555 | 13.7% |
| 17000 | Destruction of skin growth | Office | 2020 | 31 | 31 | $5,999 | $1,125 | 18.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 17 | 17 | $3,485 | $883.21 | 25.3% |
| 99201 | New patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 15 | 15 | $1,530 | $365.06 | 23.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 13 | 23 | $460.00 | $78.37 | 17.0% |
About Dr. James Young, DO
Dr. James Young, DO is a Dermatology healthcare provider based in Yankton, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487655973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Young, DO has received a total of $735.52 in payments from pharmaceutical and medical device companies, with $266.77 received in 2019. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($388.96).
As a Medicare-enrolled provider, Young has provided services to 594 Medicare beneficiaries, totaling 665 services with total Medicare billing of $20,745. Data is available for 1 year (2020–2020), covering 9 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Yankton, SD
- Active Since 08/09/2005
- Last Updated 05/14/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1487655973
Products in Payments
- COSENTYX (Biological) $122.00
- Otezla (Drug) $115.91
- Tremfya (Drug) $91.84
- STELARA (Biological) $16.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.